MX9710377A - Compuestos con propiedades de liberacion de la hormona de crecimiento. - Google Patents

Compuestos con propiedades de liberacion de la hormona de crecimiento.

Info

Publication number
MX9710377A
MX9710377A MX9710377A MX9710377A MX9710377A MX 9710377 A MX9710377 A MX 9710377A MX 9710377 A MX9710377 A MX 9710377A MX 9710377 A MX9710377 A MX 9710377A MX 9710377 A MX9710377 A MX 9710377A
Authority
MX
Mexico
Prior art keywords
compounds
growth hormone
hormone releasing
releasing properties
properties
Prior art date
Application number
MX9710377A
Other languages
English (en)
Other versions
MXPA97010377A (es
Inventor
Nils Langeland Johansen
Jesper Lau
Kjeld Madsen
Henning Thoegersen
Behrend Friedrich Lundt
Bernd Peschke
Thomas Kruse Hansen
Birgit Sehested Hansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MX9710377A publication Critical patent/MX9710377A/es
Publication of MXPA97010377A publication Critical patent/MXPA97010377A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Compuestos de la formula A-B-C-D(E)p que son utilizados para estimular la liberacion de la hormona del crecimiento desde la pituitaria.
MXPA/A/1997/010377A 1995-06-22 1997-12-18 Compuestos con propiedades de liberacion de la hormona de crecimiento MXPA97010377A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK719/95 1995-06-22
DK71995 1995-06-22
DK1371/95 1995-12-04
DK137195 1995-12-04
PCT/DK1996/000266 WO1997000894A1 (en) 1995-06-22 1996-06-19 Compounds with growth hormone releasing properties

Publications (2)

Publication Number Publication Date
MX9710377A true MX9710377A (es) 1998-03-29
MXPA97010377A MXPA97010377A (es) 1998-10-15

Family

ID=

Also Published As

Publication number Publication date
KR19990028303A (ko) 1999-04-15
PL186520B1 (pl) 2004-01-30
IL122371A0 (en) 1998-06-15
JPH11507928A (ja) 1999-07-13
JP4173541B2 (ja) 2008-10-29
PL324200A1 (en) 1998-05-11
BR9608909A (pt) 1999-03-02
AU6188296A (en) 1997-01-22
NO975992L (no) 1998-02-20
AU711104B2 (en) 1999-10-07
TW458958B (en) 2001-10-11
CA2224434A1 (en) 1997-01-09
HUP9802821A3 (en) 2000-03-28
NO975992D0 (no) 1997-12-19
HUP9802821A2 (hu) 1999-03-29
CZ287948B6 (cs) 2001-03-14
CZ408197A3 (cs) 1998-05-13
EP0833845A1 (en) 1998-04-08
WO1997000894A1 (en) 1997-01-09

Similar Documents

Publication Publication Date Title
MX9500072A (es) Compuestos con propiedades de liberacion de la hormona del crecimiento.
MY113488A (en) Compounds with growth hormone releasing properties
AP9801312A0 (en) 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor anatagonist.
BR9809189A (pt) Compostos adequados para liberação controlada do hormÈnio gnrh e seus análogos
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
GEP19981274B (en) Urinary follicle stimulating hormone, pharmaceutical composition, component of pharmaceutical composition
GR3029791T3 (en) Improved immunogenic compositions against human gastrin 17
AU2634597A (en) Compounds with growth hormone releasing properties
MY106352A (en) Hemoregulatory peptides.
HU9300192D0 (en) Polypeptide compounds promoting growth hormone emission
PL319382A1 (en) Polypeptidic compounds containing d-2-alkylotryptophane capable to promote liberation of growth hormone
IS4367A (is) CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín
EP0398084A3 (en) Nitro-substituted heterocyclic compounds
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
MX9710377A (es) Compuestos con propiedades de liberacion de la hormona de crecimiento.
GR1002598B (el) Παραγωγα επι-επιβατιδινης.
EP0717618A4 (en) STABILIZED FORMULATION FOR TABLETS
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
US5162542A (en) Substituted pyrazoline derivatives
PL257772A1 (en) An insecticide
NZ510253A (en) Neuroprotection
UA30268A (uk) Фітозасіб, стимулюючий антитілогенез

Legal Events

Date Code Title Description
FA Abandonment or withdrawal